← All Stocks

STERIS plc

STE · NYQ
$208.93+7.66%
52W Low: $195.1452W High: $269.44
Current: $208.93  ·  19% of 52-week range
HealthcareMedical DevicesNYQ
View live charts, options flow & technicals for STERIS plc → Open Dashboard

STERIS plc (STE) is a healthcare company in the medical devices industry with $6.04B in trailing revenue trading at a 25.5× trailing P/E — analyst consensus: none.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Key Statistics

Market Cap$20.37B
Revenue (TTM)$6.04B
EPS (TTM)$8.19
EPS (Fwd est.)$12.25
Employees17,937
Trailing P/E25.51
Forward P/E17.06
PEG Ratio1.74
Price / Sales3.37
Price / Book2.83
EV / EBITDA13.38
Beta (5Y)0.91

Analyst Consensus

Consensus
None
Analyst Price Target
+25.9% upside
Target: $263.12

Annual Revenue & Net Income

RevenueNet Income
'23
$4.54B
$110.00M
'24
$5.14B
$380.00M
'25
$5.46B
$610.00M
'26
$5.94B
$780.00M

Earnings History


QuarterActual EPSEstimateResult
Aug 2026
$2.59
$2.49Beat (+3.9%)
May 2026
$2.83
$2.85Miss (-0.7%)
Feb 2026
$2.53
$2.53Miss (-0.1%)
Nov 2025
$2.47
$2.35Beat (+5.0%)

Next Earnings Report

STERIS plc is next expected to report earnings on 04 Nov 2026.

Profitability

44.4%
19.2%
13.3%
Gross
Margin
Operating
Margin
Net
Margin
Revenue Growth (YoY)7.3%
Return on Equity11.4%
Return on Assets6.8%

Balance Sheet

Cash & Equivalents$480.00M
Total Debt$2.04B
Net Position$1.56B (net debt)
Free Cash Flow (TTM)$800.00M
Debt / Equity28.31

Share Ownership

Institutions 101.0%
Insiders 0.3%
Institutional figure exceeds 100% due to short selling

Dividend

Annual Rate
$2.58
Yield
1.23%
Payout Ratio
30.8%
Ex-Dividend Date
04 Sep 2026
5Y Avg Yield
0.90%

Related Stocks

LLYUNHJNJMRKABBVTMOPFEISRG

Frequently Asked Questions

What does STERIS plc (STE) do?
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, …
What is STE's market cap?
STERIS plc has a market capitalization of approximately $20.37B.
What is STE's P/E ratio?
STERIS plc trades at a trailing P/E ratio of 25.5x and a forward P/E of 17.1x, which is above the broad market average of ~25x.
How much revenue does STE generate?
STERIS plc generated $6.04B in trailing 12-month revenue.
What do analysts say about STE?
The analyst consensus rating for STERIS plc is none, with a mean price target of $263.12. That implies +25.9% upside from the current price.
When does STE report earnings?
STERIS plc is next scheduled to report earnings on 04 Nov 2026.
Does STE pay a dividend?
Yes. STERIS plc pays a dividend with a current yield of 1.23%, at an annual rate of $2.58 per share.

View live charts, options flow, gamma exposure, earnings history, and technical analysis for STERIS plc on Apsis Markets.

Open Live Dashboard →